| abstract |
pharmaceutical composition for the prevention or treatment of osteoarthritis. The present invention provides a pharmaceutical composition for the prevention or treatment of osteoarthritis, comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example, an oral dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated in a unit dosage form suitable for oral administration of rebamipide in a dose ranging from 0.5 to 50 mg / kg, preferably from 0.6 to 6 mg / kg. |